Peritoneal dialysis solutions: nutritional aspects.
Gokal
R
R
Manchester Royal Infirmary, University of Manchester, United Kingdom.
D000042:Absorption; D000596:Amino Acids / Q000008:administration & dosage / Q000627:therapeutic use; D001672:Biocompatible Materials; D002021:Buffers; D002118:Calcium / Q000008:administration & dosage / Q000627:therapeutic use; D015314:Dialysis Solutions / Q000008:administration & dosage / Q000627:therapeutic use*; D005936:Glucans / Q000008:administration & dosage / Q000627:therapeutic use; D005947:Glucose / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D000077607:Icodextrin; D007773:Lactates / Q000008:administration & dosage / Q000627:therapeutic use; D009747:Nutritional Physiological Phenomena; D018529:Nutritional Support; D009994:Osmolar Concentration; D010530:Peritoneal Dialysis; D017693:Sodium Bicarbonate / Q000008:administration & dosage / Q000627:therapeutic use; D014462:Ultrafiltration
D000596:Amino Acids; D001672:Biocompatible Materials; D002021:Buffers; D015314:Dialysis Solutions; D005936:Glucans; D007773:Lactates; D000077607:Icodextrin; D017693:Sodium Bicarbonate; D005947:Glucose; D002118:Calcium